Recent studies highlight the potential pathophysiology and presentation of immune checkpoint inhibitor–associated cutaneous ...

Bullous pemphigoid (BP), which has no FDA-approved ... with no relapse, and standard treatment with oral corticosteroids had been tailed off without the need for any rescue therapy.

Ingleton recommends that people who think they may have bullous pemphigoid go to a dermatologist to confirm the diagnosis and get help. “Get early treatment and understand that bullous ...

First up is the ADEPT study in bullous pemphigoid (BP), a rare skin condition ... with no relapse, and standard treatment with oral corticosteroids had been tailed off without the need for any ...

Patients with a rare disease called mucous membrane pemphigoid are at risk of developing squamous cell carcinoma and basal cell carcinoma, finds a new study.

“People with bullous pemphigoid live with unrelenting itch, blisters and painful lesions that can be debilitating and make it difficult to function daily. Moreover, current treatment options can ...